Literatur
- 1
Ashworth M, Medina J, Morgan M.
Effect of social deprivation on blood pressure monitoring and
control in England: a survey of data from the quality and outcomes
framework.
BMJ.
2008;
337
a2030
- 2
Cook N R, Obarzanek E, Cutler J A. et al .
Joint Effects of Sodium and Potassium Intake
on Subsequent Cardiovascular Disease. The Trials of Hypertension
Prevention Floow-up Study.
Arch Intern Med.
2009;
169
32-40
- 3
Eder M JC, Holzgreve H, Liebl M E, Bogner J R.
Der Einfluss
von Bekleidung auf die sphygmomanometrische und oszillometrische Blutdruckmessung
bei Hypertonikern.
Dtsch Med Wochenschr.
2008;
133
1288-1292
- 4
Klaus D, Middeke M, Hoyer J.
Beschränkung der Kochsalzaufnahme für die
Gesamtbevölkerung? Aufruf zur Gründung einer Task Force „Weniger
Salz für alle”.
Dtsch Med Wochenschr.
2008;
133
1317-1319
- 5
Krum H, Schlaich M, Whitbourn R. et al .
Catheter-based renal sympathetic denervation
for resistant hypertension: a multicentre safety and proof-of-principle
cohort study.
Lancet.
2009;
373
1275-1281
- 6
Lane D, Beevers M, Barnes N. et
al .
Inter-arm differences in blood pressure: when are
they clinically significant?.
J Hypertens.
2002;
20
1089-1095
- 7
Lüders S, Schrader J, Zidek W, Berger J, Böhm M, Middeke M. et al .
Prevention
of Hypertension with the ACE-inhibitor Ramipril in patients with
high-normal blood pressure (PHARAO) – a prospective, randomised,
controlled prevention trial of the German Hypertension League.
J Hypertens.
2008;
26
1487-1496
- 8
Madsen L B, Kirkegaard P, Pedersen E B.
Health-related quality of life (SF-36) during telemonitoring
of home blood pressure in hypertensive patients: A randomized, controlled
study.
Blood Press.
2008;
19
1-6
- 9
Mann J FE, Schmieder R E, McQueen M. et al .
Renal outcomes with telmisartan, ramipril, or
both, in people at high vascular risk (the ONTARGET study): a multicentre,
randomised, double-blind, controlled trial.
Lancet.
2008;
372
547-553
- 10
Middeke M.
Arterielle Hypertonie – Arzneimittel-Dosierung am Anfang
und Ende einer Therapie.
Ther Umsch.
2008;
65
577-584
- 11 Middeke M, Schulz E.
Telemetrische Blutdruck-
und Gewichtskontrolle in der Schwangerschaft. In: Goss,
Middeke, Mengden, Smetak, Hrsg Praktische Telemedizin in
Kardiologie und Hypertensiologie. Stuttgart, New York; Georg Thieme Verlag 2009: 161-168
- 12
Scheffers I, Kroon A A, Tordoir J H, de Leeuw P W.
Rheos
Baroreflex Hypertension Therapy System to treat resistant hypertension.
Expert Rev Med Devices.
2008;
5
33-39
- 13
Scheffers I, Schmidli J, Kroon A A. et al .
Sustained blood pressure reduction by baroreflex
hypertension therapy with a chronically implanted system: 2-year
data from the Rheos Debut-HT study in patients with resistant hypertension.
J Hypertens.
2008;
26
(Suppl 1)
S19
- 14
The ONTARGET/TRANSCEND
Investigators .
Rationale, design, and baseline characteristics
of 2 large, simple, randomized trials evaluating telmisartan, ramipril,
and their combination in high-risk patients.
Am Heart
J.
2004;
148
52-61
- 15
The ONTARGET Investigators .
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular
Events.
N Engl J Med.
2008;
358
1547-1559
- 16
Tissot A C, Maurer P, Nussberger J. et al .
Effect of immunisation against angiotensin
II with CYT006-AngQb on ambulatory blood pressure: a double-blind,
randomised, placebo-controlled phase IIa study.
Lancet.
2008;
371
821-827
- 17
Wirth A, Benyó Z, Lukasova M. et al .
G12-G13-LARG-mediated signaling in vascular smooth
muscle is required for salt-induced hypertension.
Nat
Med.
2008;
14
64-68
Prof. Dr. med. Martin Middeke
Hypertoniezentrum München
Dienerstr.
12
80331 München
URL: http://www.hypertoniezentrum.de
